Commercial Availability of Upgraded Diagnostic Tests for Influenza Infection
Rapid molecular assays are a modern form of molecular influenza diagnostic test with precision and high sensitivity that have seen significant advances in recent years in influenza diagnostics. The ability to detect respiratory viruses has been greatly enhanced by the reverse transcription-polymerase chain reaction (RT-PCR) and nucleic acid tests. In comparison, molecular influenza studies rely primarily on the identification by NATs of, particularly identified pathogens. NATs have some benefits over other testing devices currently in use. They may diagnose low rates of all-known influenza pathogens in clinical specimens, we do not rely on the viability of the target microbe, and they may produce findings within a clinically appropriate time frame. Owing to its ability to identify influenza viruses within 15 minutes with low to moderate sensitivity and high precision, commercial rapid influenza diagnostic tests are often used tool for influenza diagnosis.
Got questions about your regional growth of
Influenza Diagnostics Market?
Just drop us a line or call on +1 646 480 7505
Impact of COVID-19 on the Influenza Diagnostics Market
The rising prevalence of infectious diseases worldwide has raised the demand for drugs for the treatment of infectious diseases, including influenza and other diseases. The latest coronavirus disease epidemic (COVID-19), which has originated in Wuhan, China since December 2019, has caused damage in many countries across the globe. There were 6,057,853 confirmed cases, and 371,166 confirmed deaths as of 1st June 2020, according to the WHO. It's important to reduce the spread of the disease by early diagnosis during this pandemic.
When compared to COVID-19 influenza, both viruses show a similar type of illness, i.e., both cause respiratory symptoms. In addition, the two are transmitted through contact, droplets, and fomites. COVID-19 patients are misdiagnosed with influenza at early times, as a result of which their market has risen in late 2019. However, soon it was realized that in the case of COVID-19 & influenza, factors such as immunity, age group, rate of transmission, vaccination & few others are drastically different. Therefore, after recognizing the distinction between these two diseases, the need for influenza kits has become increased, and the need for a systematic testing and treatment strategy has become exceedingly significant to combat COVID-19.
Influenza Diagnostics Market: Segmentation
By Test Type
By Influenza Type
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast PeriodsView Full Report Buy This Report Now